Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reprotox.2003.10.003DOI Listing

Publication Analysis

Top Keywords

ntp-cerhr expert
4
expert panel
4
panel report
4
report reproductive
4
reproductive developmental
4
developmental toxicity
4
toxicity 2-bromopropane
4
ntp-cerhr
1
panel
1
report
1

Similar Publications

Soy infant formula contains soy protein isolates and is fed to infants as a supplement to or replacement for human milk or cow milk. Soy protein isolates contains estrogenic isoflavones (phytoestrogens) that occur naturally in some legumes, especially soybeans. Phytoestrogens are nonsteroidal, estrogenic compounds.

View Article and Find Full Text PDF

NTP-CERHR monograph on Soy Infant Formula.

NTP CERHR MON

September 2010

Soy infant formula contains soy protein isolates and is fed to infants as a supplement to or replacement for human milk or cow milk. Soy protein isolates contains estrogenic isoflavones ("phytoestrogens") that occur naturally in some legumes, especially soybeans. Phytoestrogens are non-steroidal, estrogenic compounds.

View Article and Find Full Text PDF

NTP-CERHR monograph on the potential human reproductive and developmental effects of bisphenol A.

NTP CERHR MON

September 2008

NIEHS, Research Triangle Park, NC 27709, USA.

The National Toxicology Program (NTP) Center for the Evaluation of Risks to Human Reproduction (CERHR) conducted an evaluation of the potential for bisphenol A to cause adverse effects on reproduction and development in humans. The CERHR Expert Panel on Bisphenol A completed its evaluation in August 2007. CERHR selected bisphenol A for evaluation because of the: widespread human exposure; public concern for possible health effects from human exposures; high production volume; evidence of reproductive and developmental toxicity in laboratory animal studies Bisphenol A (CAS RN: 80-05-7) is a high production volume chemical used primarily in the production of polycarbonate plastics and epoxy resins.

View Article and Find Full Text PDF

The National Toxicology Program (NTP) Center for the Evaluation of Risks to Human Reproduction (CERHR) conducted an evaluation of the potential for hydroxyurea to cause adverse effects on reproduction and development in humans. Hydroxyurea is a drug used to treat cancer, sickle cell disease, and thalassemia. It is the only treatment for sickle cell disease in children, aside from blood transfusion and, in severe cases, hematopoietic stem cell transplantation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!